TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Healing by Redness, Edema, Ecchymosis and Discharge (REEDA) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain by Visual Analog Scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fugl-Meyer Assessment (FMA) Upper Limb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kujala Patellofemoral Score Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: International Physical Activity Survey
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: 30 Second Sit and Stand Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients with Adverse Events of Special Interest (AESIs)
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in bullying
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Changes in mental health stigma
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time from randomization to delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: IFN stimulated genes expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Caregiver Strain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Hip fracture related pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in GSRS scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: postoperative 1-year mortality
Endpoint domain: Mortality/survival
Primary endpoint: Change in dimensions of keloid lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Visuospatial inhibitory attention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of the modified Demirjian method
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scoliosis Research Society Outcomes Questionnaire (SRS-22)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Core Outcome Measures Index (COMI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: ColoSense Sensitivity for Colorectal Cancer (CRC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: ColoSense Sensitivity for Advanced Adenoma (AA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: ColoSense Sensitivity for Serrated Precancerous Lesions (SPL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percentage of Participants Who use the Care4Today (C4T) Application
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of Engaged Participants who Complete End of Study Survey with Satisfaction Response Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maximum Drug Concentration (Cmax) of Setmelanotide After QD Administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Maximum Plasma Concentration (Tmax) of Setmelanotide After QD Administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-Time Curve Over the Dosing Interval (AUC0-tau) of Setmelanotide After QD Administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of serum leptin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in Goal-attainment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ostomy avoidance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of unsolicited systemic adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Geometric Mean Titers (GMTs) of neutralizing antibody (nAb) titers post-primary vaccination at Day 29
Endpoint domain: Physiological/clinical
Primary endpoint: Proportion of participants retained in the intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Self-Efficacy (CASE-Cancer)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PWV measurement bias
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: PWV measurement deviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Anxiety Levels of Mothers
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Heartbeat of mothers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Breathing rate of mothers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Blood pressure of mothers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Oxygen saturation of mothers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: microRNA expression profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Summed Pain Intensity Difference (SPID24)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chronic neck pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disability based on Neck Disability Index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Quality of Life based on Cognitive Exercise Therapy Approach-Biopsychosocial Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Ardouin Scale of Behaviour in Parkinson's Disease (ASBPD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of circulating tumour DNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Perioperative Anxiety Level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Subjective Cognitive Decline
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes of muscular activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Short-term clinical utility of genetic testing
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Parent-perceived (personal) utility of genetic testing
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Physician's Global Assessment (PGA) 0/1 response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time from date of treatment initiation to date of discontinuation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Changes in Stroop test performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes in neuroelectrical activities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of stressed patients
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in youth's intention to delay sexual intercourse
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Disaster Literacy Scale (DLS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Nurses' Perception of Disaster Preparedness Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Self-rated Quality of Life (QOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Complete aneurysm occlusion with no recurrence or re-treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Major stroke or non-accidental death within 30 days, or major ipsilateral stroke or neurological death between 31 days and 12 months
Endpoint domain: Mortality/survival
Primary endpoint: Change in measure of naming
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Subject reported symptom improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Prevalence of Female Genital Schistosomiasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: HIV-1 RNA viral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parent Attendance at Family-Centered Rounds
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Rotator cuff functional strength ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in metagenomic profile of the gut microbiome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Time to laboratory value normalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Macrophage Activation Syndrome (MAS) laboratory remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hemodialyzer performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in marginal discoloration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dose Accuracy
Endpoint domain: Resource use
Primary endpoint: Patient reported experience
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: incidence of target lumen failure (TLF)
Endpoint domain: Adverse events/effects
Primary endpoint: Substance Use Stigma
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Efficacy of sentinel lymph node biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Grade 3 or higher adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Pain after laparoscopic cholecystectomy surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety after laparoscopic cholecystectomy surgery
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Gastrointestinal system functions after laparoscopic cholecystectomy surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Patient and clinician acceptability of the trial process and ESWT
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of Participants With Cryptosporidium Infection
Endpoint domain: Adverse events/effects
Primary endpoint: Patient perception VISA-P
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Arterial blood gas and spirometry values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient mortality after treatment
Endpoint domain: Mortality/survival
Primary endpoint: Change From Baseline in the International Prostate Symptom Score (IPSS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mother-to-Infant Bonding Scale (ABBÖ)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maternal Attachment Scale (MBS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Parental Self-Efficacy Scale (EÖSÖ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Barkin Maternal Function Scale (BAFÖ)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of self-reports of patient distress/discomfort
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of days taken for patients to die after being identified by hospice staff
Endpoint domain: Mortality/survival
Primary endpoint: Number of successful informed consents obtained from family members
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Overall satisfaction score with post operative pain control
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Successful Sequencing Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Screen Positive Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attitude Scores Regarding Sexually Transmitted Diseases
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Attitude Scores Regarding Sexuality
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Attitude Scores Regarding Sexual Behaviors
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Attitude Scores Regarding Sexual Health and Personal Hygiene
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Attitude Scores Regarding Gender Roles
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Attitude Scores Regarding Sexual Abuse
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Annualized growth velocity (AGV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to treatment with VOXZOGO™ (vosoritide), if prescribed
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Recommended Phase 2 dose (RP2D) finding
Endpoint domain: Adverse events/effects
Primary endpoint: Level of depression and anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Respiratory variables (FEV1, FEV6, FEV1/FEV6)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Prosocial behavior
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change in aerobic performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in PINES Network activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Zanarini Rating Scale for Borderline Personality (ZAN-BPD)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Correct predictions for redness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reclassification rate of the treatment strategy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abstinence from Substance Use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Decrease in Addiction Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Motivation to Change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in Substance Craving
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of Surgical site infections
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of Wound dehiscence
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of Seroma
Endpoint domain: Adverse events/effects
Primary endpoint: Dose response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Dose-related SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Level of Plasma Free Hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Volume of Blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Discoloration of teeth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ⍺-synuclein seeding activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of adverse event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Absorption of curcumin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of wear
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Preference
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: emergence rate of systemic anthrax infection
Endpoint domain: Adverse events/effects
Primary endpoint: rate of resolution of edema and healing of lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Isolation of human respiratory virus specimens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Feasibility of visualization of the ureters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Asthma or ABPA exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax (candesartan cilexetil)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUClast (candesartan cilexetil)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Autobiographical memory specificity
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Standard deviation of the mean R-to-R segment (SDANN)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in knowledge of hospital-acquired pressure sores risk
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maximum tolerated dose or maximum administered dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of cardiovascular and cerebrovascular events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Difference in serum LPS concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Lung cancer detection rate differences
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Predicted Area under curve (AUC) value > 0.8
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Target Stone status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment related complication
Endpoint domain: Adverse events/effects
Primary endpoint: Duration of new non-invasive ventilation or high flow oxygen use
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Patient-reported functional outcome 1 year after injury
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: degree of erectile dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: response to tadalafil treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clearance of persistent cervical hrHPV infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Prevalence of adverse cardiac events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in arm function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in heat strain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time from request of epidural anesthesia to anesthesiologist arrival
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change From Baseline on the MAPS-D Score at Maximum Contraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-year primary patency rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in speech-in-noise perception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Testosterone Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Estradiol Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Estrone Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Pupil's reaction to light
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: spontaneous preterm birth (sPTB) <34 weeks' gestation
Endpoint domain: Mortality/survival
Primary endpoint: Obsessive-Compulsive Inventory-Revised score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Decrease in BMI of at least 1 BMI unit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in C Reactive Protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: skin cleanliness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Real-world response rate (rwRR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Any treatment-emergent immune-mediated adverse event (imAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Assessment of topical skin tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Improvement of hypercapnia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Efficacy of triplet combination therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of survival free patients of any major hemocompatibility related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Presence of bony erosions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Patients using 1 or more RP treatments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of Receptor Binding Domain (RBD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes